Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiLe-1: Levosimendan for Postoperative AKI in Pediatric Heart Surgery
NCT02232399Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Oct 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of levosimendan in acute kidney injury (AKI), sponsored by University of Gothenburg. Started Oct 2014; status: completed.
02
Drugs
levosimendan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02232399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232399.